Document is current
Any future updates will be listed below
-
Authors
Yang, Chih-Chao
Chen, Kuan-Hung
Yue, Ya
Cheng, Ben-Chung
Hsu, Tsuen-Wei
Chiang, John Y.
Chen, Chih-Hung
Liu, Fanna
Xiao, Jie
Yip, Hon-Kan
-
Funding
Funding for this research was provided by:
Kaohsiung Chang Gung Memorial Hospital (CMRPG8L1411)
- License Information
-
More Information
Article History
Received: 1 January 2024
Accepted: 21 July 2024
First Online: 27 August 2024
Declarations
:
: Title of the approved project: To explore the molecular mechanism of SGLT2 inhibitor in modulating oxidative stress through AMPK pathway for cardiorenal protection in cardiorenal syndrome. Name of the institutional approval committee: All animal procedures were approved by the Institute of Animal Care and Use Committee (IACUC) at Kaohsiung Chang Gung Memorial Hospital. Approval number: Affidavit of Approval of Animal Use Protocol No. 2021062210. Date of approval: Jun. 22, 2021.
: Not applicable.
: The authors declare no competing interests.
